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Introduction
The widespread use of plastic bags in
routine blood bank procedures has been
attended by concern about the accumulation
of substances from the plastic containers in
the blood products and the biologic effects
of these substances (1-11). Most poly(vinyl
chloride) plastic bags contain di-2-ethylhexyl
phthalate (DEHP) to make them pliable
enough to prevent breakage (2, 5). This
material has been shown to accumulate in
the plasma of stored whole blood (12).
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Our study was undertaken to measure the
amount of DEHP in the plasma separated
from whole blood that had been anticoagu-
lated with either acid-citrate-dextrose
(ACD) or citrate-phosphate-dextrose (CPD)
and stored in poly(vinyl chloride) plastic
containers. We also measured the amount of
DEHP in bioriented polyolefin and in poly-
ethylene plastic containers used in freezing
human red cells and platelets, and the ac-
cumulation of DEHP in four different anti-
coagulants stored at room temperature and
in 0.9% sodium chloride solution and solu-
tions used for rejuvenation of human red
cells stored in poly(vinyl chloride) plastic
containers. The amount of DEHP present in
thawed glycerolized red cells stored in plas-
tic containers at either -80°C or -150°C for
up to 2 years, and the amount of DEHP in
washed liquid-stored red cells and previously-
frozen deglycerolized red cells were also
measured.
Because CPD is now suggested as the anti-
coagulant of choice for collection of blood
January 1973 103(13), components prepared from CPD whole
blood were studied, i.e., platelet concen-
trates (PC), platelet-rich plasma (PRP),
platelet-poor plasma (PPP), washed platelets,
and washed red cells. Storage of platelet
concentrates at 40C and 220C was studied
because it has been recommended that plate-
let concentrates be stored at 220C for up to
72 hr (14). The effects of DEHP on platelet
viability and function in vivo were also
studied.
Materials and Methods
Collection and Preparation of the Whole
Blood Fractions
Approximately 450 ml of whole blood
was collected in double-pack poly(vinyl chlo-
ride) (PVC) blood bags containing either
ACD or CPD anticoagulants. The plastic
used in the collection bag containing the
anticoagulant was Travenol PL-130, and that
in all the transfer packs was Travenol
PL-146. The whole blood was stored at 4°C
for up to 34 days. Each of 10 units of
ACD-stored whole blood was washed by
continuous-flow centrifugation by use of
either Haemonetics Corporation's reusable
stainless steel washing bowls or Baxter Lab-
oratories' collapsible disposable poly(vinyl
chloride) bags (15-17). Two liters of buf-
fered saline (0.9 gm/100 ml NaCl containing
0.2 g-% glucose and buffered to pH 6.8 with
0.065 g-% disodium phosphate) were used to
wash each unit within 15 min (Table 1)
(17). Samples were taken during storage of
the whole blood at 40C and before and after
washing of each unit.
Freeze-Preservation
The red cells were usually stored in either
ACD or CPD at 40C for about 7 days prior
Table 1. Removal ofDEHP bywashingwhole blood collected in ACD
and stored at40C for atleast 33 days.
Total amount Total amount
Storage of DEHP pre- of DEHP post- DEHP
at 40C, wash unit, wash unit, remaining,
days Wash method mg mg %
34 Elutramatic 8.52 0.21 2.46
33 " 7.63 0.00 0.00
33 " 16.76 0.13 0.01
33 " 9.92 0.15 1.50
Mean 10.71 0.12 0.99
SD ± 4.14 0.09 1.20
SE ± 2.07 0.04 0.60
33 Blood processor #10, 27.45 0.21 0.75
33 reusable stainless 17.00 0.15 0.89
steel bowl
33 7.04 0.11 1.56
33 " 10.87 0.14 1.28
33 17.15 0.56 3.26
33 21.80 0.24 1.10
Mean 16.89 0.24 1.49
SD ± 7.33 0.17 0.92
SE ± 2.99 0.07 0.38
Environmental Health Perspectives 104to glycerolization and freezing, either 40%
(w/v) glycerol and -80°C storage or 20%
(w/v) glycerol and -150°C storage being used
(18-20). The methods for addition and re-
moval of the glycerol were as described
below. Outdated red cells were rejuvenated
prior to freezing (21). After the ACD or
CPD whole blood or the concentrated red
cells had been stored at 40C for at least 21
days and as long as 36 days, a 50-ml volume
of a rejuvenation solution was added to each
unit. The rejuvenation solution contained
per liter either (a) 50 mmole pyruvate (sodi-
um salt), 50 mmole inosine, 100 mmole
glucose, and 50 mmole phosphate, and the
pH was adjusted to 7.2 (PIGP) or (b) 50
mmole pyruvate, 50 mmole inosine, 100
mmole glucose, 50 mmole phosphate, and 5
mmole adenine, and the pH was adjusted to
7.2 (PIGPA). Each unit of blood was then
placed in a water-tight plastic envelope and
incubated at 370C with agitation for 60 min.
Units of whole blood and of concentrated
red cells incubated without the rejuvenation
solution served as controls.
Meryman method-Within 6 days of stor-
age as whole blood at 40C in either ACD or
CPD and after incubation with or without
the rejuvenation solution, the outdated red
cells were concentrated and all the visible
plasma removed. A 100-ml portion of a
glycerol solution containing per 100 ml 57.1
g glycerol, 1.6 g sodium R-lactate, 0.03 g
KC1, 0.04 g MgCl2, and 0.06 g disodium
phosphate buffered to pH 7.2, was added to
250 ml of concentrated red cells (22). A
total of 400 ml of the glycerol solution was
added to the concentrated red cells whose
weight ranged from 275 to 325 g. The red
cells were then frozen to -80°C and stored
up to 20 months in a poly(vinyl chloride)
plastic bag (TA-20, P.L-146) (Table 2). The
red cells were thawed, and deglycerolization
was accomplished by the continuous-flow
centrifugation wash method with the use of
hypertonic NaCl solutions. The thawed red
cells were diluted with 150 ml of 12 g-%
NaCl buffered to pH 7.2 with 0.15 g-%
disodium phosphate. They were then washed
with 2 liters of 1.6 g-% NaCl buffered to
pH 7.2 with 0.018 g-% disodium phosphate
and 1 liter of 0.9 g-% NaCl containing 0.2
g-% glucose buffered to about pH 6.8 with
0.065 g-% disodium phosphate.
Huggins method-Concentrated red cells
were prepared from ACD anticoagulated
whole blood after storage for up to 3 days
at 4°C. The red cells were glycerolized by
adding an equal volume of glycerolizing solu-
tion containing 8.6M glycerol, 8% glucose,
1% fructose, and 0.3% disodium ethylenedia-
minetetracetic acid (Na2EDTA) (23). The
glycerolized red cell mass was slowly frozen
to -80°C and stored at that temperature for
up to 27 months in a poly(vinyl chloride)
plastic container (Table 2). The red cells
were deglycerolized by using the continuous-
flow centrifugation wash method with a
glycerol-lactate-NaCl solution containing 1
liter of 10 g-% glycerol and 5.6 g-% sodium
lactate, 2 liters of 3.5 g-% sodium R-lactate,
and a liter of 0.9 g-% NaCl containing 0.2
g-% glucose buffered to pH 6.8 with 0.065
g-% disodium phosphate (19).
Rowe method-Concentrated red cells
were prepared from ACD-anticoagulated
blood after storage at 40C for up to 10 days
and from ACD blood stored at 40C for
27-29 days after incubation with PIGPA
solution. An equal volume of a solution con-
taining per 100 ml 2.88 g mannitol, 0.65 g
NaCl, and 35 g glycerol was added to the
red cell volume (20, 24). The glycerolized
red cells were transferred to a bioriented
polyolefin plastic container held in an alum-
inum container during immersion in liquid
nitrogen for 5 min. The red cells were stored
for about 19 months in gas phase of liquid
nitrogen at -1500C in an LR-1000 Linde
liquid nitrogen freezer. After thawing, de-
glycerolization was accomplished by a
continuous-flow centrifugation wash method
by use of the ADL-10 washing machine with
either reusable stainless steel or rigid disposa-
ble polycarbonate bowls. The wash solution
consisted of 500 ml of 5.6 g-% sodium R-
lactate. The thawed diluted glycerolized red
cells were washed with 2 liters of 0.9%
NaCl containing 0.2 g-% glucose buffered to
pH 6.8 with 0.065 g-% disodium phosphate
January 1973 105Table 2. DEHP levels in supernatant of the thawed glycerolized red cells.
Time of DEHP in supernatant
Prefreeze Temperature frozen of thawed
Anti- storage at Method of Container for of storage, storage, glycerolized red cells
coagulant 40C, days glycerolization frozen storage 0C mos. mg-%
ACD 3 Huggins Poly(vinyl chloride)a -80 27 1.00
ACD 2 Huggins Poly(vinyl chloride)a -80 27 1.00
CPD 6 Meryman Poly(vinyl chloride)b -80 13 0.60
CPD 2 Meryman Poly(vinyl chloride)b -80 20 0.32
ACD 9 Rowe Bioriented polyolefinc -150 19 1.08
ACD 10 Rowe Bioriented polyolefinc -150 19 1.20
ACD 5 Meryman Bioriented polyolefinc -80 11 0.80
ACD 5 Meryman Bioriented polyolefinc -80 11 0.70
aInternational Equipment Co., Needham, Mass.
bTravenol Laboratories, Morton Grove, Ill.
cUnion Carbide Corp., Chicago, Ill.
(20). Samples were obtained from the super-
natant of the red cells after storage either at
-80°C with 40% (w/v) glycerol or at
-150°C with 20% (w/v) glycerol and from
the washed previously frozen red cells.
Preparation of the
Platelet-Poor Plasma,
Washed Platelets, and
Platelet-Rich Plasma,
Platelet Concentrates,
Washed Red Cells
Within 4 hr of collection platelet concen-
trates were prepared from CPD whole blood
at room temperature (22 ± 1°C) by cen-
trifugation. The platelet-poor plasma,
platelet-rich plasma, and platelet concen-
trates were stored at either 4°C or 22CC in
transfer packs (Fenwal TA-2 and TA-3)
made of the plastic PL-146. Some of the
units of whole blood were centrifuged at
4500g for 3 min, and the platelet-rich plas-
ma was removed. A 20 ml volume of con-
centrated red cells was washed with an equal
volume of buffered 1.6 g-% sodium chloride
on three separate occasions, and the super-
natant medium and the washed red cells
were analyzed for DEHP.
Platelet counts were made on the platelet-
rich plasma. The platelet-rich plasma was
then certrifuged at 4500g for 5 minutes to
concentrate the platelets. The platelet con-
centrate and the platelet-poor plasma were
then stored at 22°C or 40C for up to 3
days. The platelet concentrate was centri-
fuged at 6975g for 5 min, and the super-
natant of the platelet concentrate was re-
moved for DEHP assay. The platelet button
was then suspended in 10 ml of 0.9% non-
buffered isotonic sodium chloride and
centrifuged at 6975g for 5 min. The super-
natant medium of the washed platelets and
the washed platelets themselves were assayed
for DEHP. The number of platelets in the
platelet button was estimated from the
platelet count of platelet-rich plasma and the
volume of platelet-rich plasma used to pre-
pare the platelet concentrate.
DEHP in Solutions Stored in Poly(vinyl
chloride) (PVC) Plastic Containers, in Other
Plastics, and in Anticoagulants Stored in
PVC at Room Temperature
Samples were obtained for measurement
of DEHP content in sodium chloride solu-
Environmental Health Perspectives 106tion (0.9%) that was stored in poly(vinyl
chloride) plastic (PL-146) for up to 6
months at room temperature, and in the
rejuvenation solutions (PIGP and PIGPA)
that were stored in poly(vinyl chloride) plas-
tic transfer packs for up to 3 months at
room temperature. The ACD, CPD, heparin,
and sodium citrate anticoagulants that were
stored in poly(vinyl chloride) plastic con-
tainers (PL-130) at room temperature for up
to 427 days were also analyzed for DEHP.
Bioriented polyolefin (Hemoflex, Union
Carbide Corp.) and polyethylene (Cryocyte,
Fenwal Laboratories) were cut into 1-mm
squares and put into a 2:1 chloroform-
methanol mixture for up to 30 hr at room
temperature, and the extracts were analyzed
for DEHP.
Preparation of the Samples for DEHP
Analysis
Aliquots of platelet-rich plasma, platelet-
poor plasma, the supernatant of the platelet
concentrates, washed red cells, and the
supematant solution of washed red cells and
washed platelets were lyophilized. A volume
of chloroform-methanol mixture (2:1) was
added to the lyophilized sample and mixed
by vigorous stirring. The suspension was
filtered and the residual material washed
with CHCl3:CH30H. The liquid phase was
then mixed with an equal volume of distilled
water and centrifuged. The upper layer con-
taining the methanol and water was dis-
carded. Silicic acid was added to the remain-
ing chloroform phase and mixed for 1 min
with a vortex mixer. After centrifugation,
the chloroform was decanted and evapo-
rated, leaving a white powder that was dis-
solved in reagent-grade methanol. The
samples were then stored at 4°C for 1 hr.
The clear supernatant prepared by centrifu-
gation was analyzed. The washed platelets
were extracted without lyophilization in the
manner described above.
Separation of DEHP from methanol was
achieved by using a 6-ft column of 3% SE
30 on acid-washed Chromosorb W at 2000C
oven temperature, 3000 C injection port
temperature, and 3000 C flame detection
temperature in a Hewlett-Packard Model
7620A gas chromatograph. Identification of
the material extracted as DEHP was made
on the basis of retention time and by the
addition of DEHP to nonbuffered 0.9 g-%
sodium chloride which was extracted in a
similar manner (R. J. Jaeger, to be pub-
lished). Recovery of the additional DEHP
averaged 87%. This was quantitated by meas-
uring the area of the peak (calculated by
multiplying its width at half the height of
the peak by the peak height). The DEHP
values were not corrected for the incomplete
recovery of DEHP.
Effects of DEHP on Platelet Aggregation in
Vitro
Fresh platelet-rich plasma was prepared
from sodium citrate-anticoagulated blood ob-
tained from normal volunteers. DEHP (13
g-%) purchased from Polysciences Inc. was
mixed with 12-82 mmole methanol. The
DEHP-methanol mixture was added to the
platelet-rich plasma to achieve final DEHP
levels of 5-40 mg-%. The maximum amount
of methanol used with the DEHP was added
to the platelet-rich plasma to measure the
effect of methanol on the aggregation pat-
terns. In vitro aggregation of the platelet-rich
plasma with and without DEHP to
epinephrine, collagen, and ADP was studied.
Aggregation studies were performed in a
modified Kalmedic Instruments Fragiligraph
at 370 C by means of the technic of Born
(25). Collagen extracts were prepared as de-
scribed previously (26), and each batch was
diluted so that an aliquot of 5 ml produced
maximal aggregation with 2 ml of citrated
platelet-rich plasma. Adenosine diphosphate,
collagen, and epinephrine were diluted in
0.05M imidazole-buffered saline, pH 7.4.
Phase microscopy platelet counts of whole
blood were performed, and the platelet-rich
plasma was counted with the Coulter Coun-
ter Model B.
January 1973 107Platelet Viability and Function
Platelet concentrates prepared from CPD
whole bood were stored at either 40 C or
220 C for up to 72 hr before transfusion.
The recovery in vivo and lifespan were
studied by 51Cr labeling of the platelets as
described by Murphy and Gardner (14). The
index of therapeutic effectiveness (ITE) was
estimated from the recovery in vitro multi-
plied by the 51Cr recovery in vivo. The
hemostatic effectiveness of preserved plate-
lets was evaluated by their ability to correct
the prolonged bleeding time produced by
administration of 650 mg of aspirin to
healthy volunteers. The bleeding time of
these volunteers was measured by the proce-
dure described by Mielke et al. (27) before
and after aspirin ingestion and after infusion
of the platelet concentrates. Twenty-four
hours after ingestion of the aspirin the
bleeding time was measured, and the volun-
teer was given autologous stored platelets.
The bleeding time was then measured 2, 24,
48, 72, and 96 hr after infusion of the
platelet concentrate. The platelets were ob-
tained prior to aspirin treatment and stored
in either PL-146 or bioriented polyolefin for
at least 24 hr at 40C or at 22°C. After
storage of the platelet concentrates for 48 hr
at either 40C or 22°C the supernatant of the
platelet concentrates was added to fresh
autologous platelets. These platelets were
then stored for 24 hr at either 40C or 22°C
to determine the effect of the additional
DEHP in the supematant on the platelet
viability in vivo and the ability to correct a
prolonged bleeding time induced by aspirin
in healthy individuals (26-29).
Results
DEHP was recovered in significant quan-
tities from plasma prepared from whole
blood stored in poly(vinyl chloride) bags
(PL-130) at 40C. The DEHP accumulation
was greater in the whole blood stored in the
ACD anticoagulant than in that stored in the
CPD anticoagulant; 0.360 mg-% DEHP
accumulated per day in ACD, and 0.268
mg-% per day in CPD (Fig. 1). The amount
of DEHP in CPD whole blood on the day of
collection was about half that found in the
ACD whole blood; 2.07 mg-% in CPD, and
3.14 mg-% in ACD (Fig. 1). The plasma
separated from ACD whole blood had sig-
nificantly more DEHP on the day of collec-
tion than did the plasma obtained from CPD
whole blood, and the increase in DEHP in
the plasma of ACD whole blood after stor-
age at 40C for up to 30 days was significant-
ly greater than in the units of CPD whole
blood stored at 40C for the same period (F
= 18.68, p <0.01, n = 94).
Table 1 shows that after washing liquid-
stored ACD whole blood by continuous-flow
centrifugation procedures about 0.2 mg
DEHP remained in the unit. Removal of
about 98% of the DEHP was achieved by
the continuous-flow centrifugation proce-
dures.
Table 2 shows that after storage in the
frozen state at either -80°C or -150°C for
at least 2 years in either bioriented poly-
olefin or poly(vinyl chloride) plastic con-
tainers, the amount of DEHP found in the
thawed glycerolized red cells containing
either 40% (w/v) or 20% (w/v) glycerol cor-
related with the amount of DEHP present at
the time of freezing. The data suggest that
the DEHP level did not increase during stor-
age in the frozen state.
Tables 3 and 4 show the amount of
DEHP in the washed previously frozen red
cells preserved by using either 40% (w/v)
glycerol and storage at -80°C or 20% (w/v)
glycerol and storage at ---150°C contained
about 1 mg per unit. The amount of DEHP
in the unit prior' to glycerolization and freez-
ing was calculated from data reported in
Figure 1.
Table 5 shows that no DEHP was found
in either the polyethylene or the bioriented
polyolefin plastic containers. No DEHP was
found after storage of the sodium chloride
solution (0.9%) or the PIGP or PIGPA re-
juvenation solutions in the poly(vinyl chlo-
ride) plastic bags at room temperature for
up to 6 months. Table 6 shows that no
Environmental Health Perspectives 108Table 3. Effect of washing red cells prepared from ACD-coliected whole blood frozen with 20% (w/v) glycerol
at -150°C or 40% (w/v) glycerol at -800C.a
Time of Estimated DEHP
storage at Time of DEHP in DEHP remaining
40C prior Rejuvenation storage in unit prior in washed Total after
to freezing prior to Plastic frozen state to freezing red cells DEHP washing
days freezing container days mg/unit mg-% mg/unit S
20% (w/v) Glycerol
7 None Bioriented 62 16.0 0.09 0.55 3.3 polyolefin
7 None Bioriented 62 16.0 0.09 0.56 3.4 polyolefin
7 None Bioriented 62 16.0 0.16 0.43 2.6 polyolefin
Mean 7 62 16.0 0.11 0.51 3.1
40% (w/v) Glycerol
26 PIGPA Polyethylene 69 36.0 0.60 1.66 4.6
30 PIGPA Polyethylene 35 40.2 0.45 1.04 2.5
31 PIGPA Bioriented 28 41.2 0.50 0.97 2.4 polyolefin
33 PIGPA 28 43.3 0.50 1.05 2.4 PTGPA polyolefin
32 PTGPA Bioriented 28 42.2 0.60 1.56 3.7 polyolefin
Mean 30.4 37.6 40.4 0.53 1.25 3.1
aThe thawed glycerolized red cells were washed in disposable poly (vinyl chloride) plastic bags in the Elutramatic red
cell washer.
Tahle 4. Effect of washinm fed cells frozen with 20%7 (w/v) glycerol at -1500C or 40% (w/v) glycerol
at -800C in bioriented polyolefin plastic bags.a
Time of Estimated DEHP
storage at Time of DEHP in DEHP remaining
Anti- 40C prior Rejuvenation storage in Type of unit prior in washed Total after
coagu- to freezing, prior to frozen state, ADL to freezing, red cells, DEHP, washing,
lant days freezing days bowl mg/unit mg-% mg/unit %
20% (w/v) Glycerol
27 PIGPA
27
27
PIGPA
PIGPA
29 PIGPA
14 Disposable 37 0.68
28 Disposable 37 0.26
99 Reusable
13 Reusable
37 0.34
39 0.32
2.57
0.96
1.32
1.17
38.5 37.5 0.40 1.50 4.0
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Mean 27.5
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2.6
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109Table 4. Effect of washing red cells frozen with 20% (w/v) glycerol at -1500C or 40% (w/v) glycerol
at -800C in bioriented polyolefin plastic bags.a (continued)
Time of Estimated DEHP
storage at Time of DEHP in DEHP remaining
Anti- 40C prior Rejuvenation storage in Type of unit prior in washed Total after
coagu- to freezing, prior to frozen state, ADL to freezing, red cells, DEHP, washing,
lant days freezing days bowl mg/unit mg-% mg/unit %
40% (w/v) Glycerol
ACD 5 PIGPA 233 Reusable 14 0.10 0.39 2.7
ACD 5 PIGPA 233 Reusable 14 0.18 0.70 4.9
ACD 5 PIGPA 233 Reusable 14 0.20 0.78 5.5
ACD 5 PIGPA 233 Reusable 14 0.12 0.47 3.3
ACD 8 None 377 Reusable 17 0.20 0.79 4.5
ACD 30 PIGPA 13 Disposable 40 0.60 2.20 5.5
CPD 34 PIGPA 8 Disposable 32 0.40 1.45 4.5
CPD 34 PIGPA 8 Disposable 32 0.30 1.13 3.5
CPD 36 PIGPA 26 Disposable 33 0.60 2.18 6.5
Mean 18 152 23 0.30 1.12 4.5
aThe thawed glycerolized red cells were washed in the blood processor, Model
or disposable rigid polycarbonate bowls.
CPD y'2.07 f 0.26 (x)
6i (a) r 0.751
6
p<0.00I 4,
I Gi w < ool *9
ACD |12t~~~~~~~~~~CPD
4 7;. go8 8
O .
0 4 8 12 16 20 24 28 32
Days Stored at 40
FIGURE 1. Level of di-2-ethylhexyl phthalate
(DEHP) in the plasma of whole blood collected
and stored in either acid-citrate-dextrose (ACD)
or citrate-phosphate- dextrose (CPD) in poly
(vinyl chloride) plastic bags (PL-130).
DEHP was found in any of the four anti-
coagulants stored at room temperature for
up to 427 days in the poly(vinyl chloride)
plastic containers (PL-130).
10, using reusable stainless steel bowls
The supernatant of the platelet concen-
trates prepared from CPD blood contained
the highest concentration of DEHP of all the
components reported in Table 7; after stor-
age at 40 C for up to 3 days it contained
about five times the amount found in
platelet-poor plasma, and about four times
the amount in platelet-rich plasma. After
storage at 22°C for up to 3 days it con-
tained about nine times as much DEHP as
did the platelet-poor plasma, and three times
as much as the platelet-rich plasma (Table
7). There was a threefold increase in the
amount of DEHP that accumulated in the
supernatant of the platelet concentrate after
storage at 220 C over that after storage at
40 C. The washed red cells and washed plate-
lets contained a very small amount of DEHP
(Table 7).
Figure 2 shows the 51Cr survival of
autologous platelet concentrates prepared
from CPD whole blood. When platelet con-
centrates were stored at 22°C for up to 72
hr, the recovery in vivo of 51Cr radioactivity
Environmental Health Perspectives 110Table 5. Amount of DEHP present in solutions stored in plastic containers
and in plastic containers themselves.
Solution
PIGP
PIGPA
0.9% NaCl
0.9% NaCl
Chloroform-methanol
Chloroform-methanol
Chloroform-methanol
Chloroform-methanol
Time of
room temperature
storage
86 days
86 days
191 days
191 days
3 hr
30 hr
3 hr
30 hr
DI
m
EHP,
Ig-% Container information
0 Travenol PL-146, Lot ZF77P3
0 Travenol PL-146, Lot ZF77P3
0 Travenol PL-146, Lot NP18F5
0 Travenol PL-146, Lot NP18F5
0 Union Carbide bioriented polyolefin,
Style 3160-3A, Lot FP7103
0 Union Carbide bioriented polyolefin,
Style 3160-3A, Lot FP7103
O Travenol polyethylene, Code 4R2955,
Lot 24R1
0 Travenol polyethylene, Code 4R2955,
Lot 24R1
Table 6. Level of DEHP in anticoagulants stored in poly(vinyl chloride) plastic
containers (PL-130) at room temperature.
Anticoagulant
Acid-citrate-dextrose (ACD)
Citrate-phosphate-dextrose (CPD)
4% Sodium citrate
Heparin
Acid-citrate-dextrose (ACD)
Citrate-phosphate-dextrose (CPD)
4% Sodium citrate
Heparin
Plastic container
Travenol, JD-2 (#1)
Travenol, JF-25 (#1)
Travenol PC-210 (#1)
Travenol JH-1N (#1)
Travenol, JD-2 (#2)
Travenol, JF-25 (#2)
Travenol, PC-210 (#2)
Travenol, JH-1N (#2)
Time of storage
at 22 C, days
290
218
248
427
290
218
248
427
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DEHP,
mg-%
0
0
0
0
0
0
0
0
illTable 7. Amount of DEHP in platelet-rich plasma (PRP), platelet-poor plasma (PPP), supernatant of the platelet
concentrate (PC), washed platelets, and washed red cells, prepared from CPD-collected whole blood.
DEHP Content
Super- Super-
Tem- Super- natant natant
pera- natant Washed Washed platelets, of washed Washed of washed
Storage ture, PRP, PPP, of PC, platelets mg per platelets, red cells red cells
time,hr 'C mg-% mg-% mg-% mg-% 1.0 x 1011platelets mg-% mg-% mg-%
24 4 Mean 1.04 1.27 6.72 0.35 0.19 0.31 0.11 0.25
SD ±0.11 0.28 2.13 0.08 0.08 0.23 0.13 0.22
SE ±0.06 0.12 0.95 0.03 0.04 0.11 0.07 0.11
n 4 5 5 5 5 5 4 4
24 22 Mean 5.10 1.89 19.94 1.03 0.42 1.24 0.50 1.51
SD ±1.04 0.81 5.38 0.29 0.10 1.72 0 00 0.64
SE ±0.52 0.36 2.40 0.13 0.05 0.77 0.00 0.32
n 4 5 5 5 5 5 4 4
72 4 Mean 2.99 2.23 11.14 0.52 0.26 0.38 0.20 0.69
SD ±0.17 1.92 2.42 0.31 0.08 0.12 0.16 0.19
SE ±0.08 0.86 1.08 0.14 0.04 0.05 0.08 0.10
n 4 5 5 5 5 5 4 4
72 22 Mean 15.31 5.82 44.26 1.28 0.56 0.84 1.10 3.58
SD ±3.78 1.98 17.47 0.59 0.13 0.17 0.48 1.15
SE ±1.89 0.88 7.81 0.27 0.06 0.08 0.24 0.57
n 4 5 5 5 5 5 4 4
70L of the infused platelets during the 2-hr post-
1, transfusion period reflected the preservation
60 ±/iS.E. -NoSfogw injury; the longer the storage at 22 C, the
k a-- 24r-22C poorer the recovery in vivo immediately
tz SC 5 \ \0 r- 72he.-22c after transfusion. The lifespan of fresh plate-
lets and of those concentrates stored for up
X L\ ~\\\\ to 72 hr at 22°C was about 8 days, and the
e 3O^2\\<u4\ removal rates were linear.
20 ,., \>\\\u\\u\9tFigures 3 and 4'show that the addition of
up to 40 mg-% DEHP in methanol to
lo- \platelet-rich plasma did not significantly
affect the response of fresh platelet-rich plas-
2 3 4 5 6 7 8 9 ma to ADP, epinephrine, or collagen.
DAYS Figure 5 shows the effect of the trans-
fusion of platelet concentrates stored at
FIGURE 2. 5ICr survival of autologous platelet 22 C for 24 hr in either poly(vinyl chloride)
concentrates prepared from CPD whole blood, plastic (PL-146) or bioriented polyolefin
Fresh platelet concentrates and platelet concen- containers on the prolonged bleeding time
trates after storage at 22 C for up to 72 hr were
studied. The mean and standard error (SE) for produced by treatment of a healthy volun-
each group are reported. teer (J. F.) with 650 mg aspirin. Storage of
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FIGURE 4. Effects of addition of DEHP to
platelet-rich plasma on platelet aggregation in
vitro to epinephrine.
platelet concentrates in poly(vinyl chloride)
plastic containers with either 20 mg-% (Fig.
5A) or 35 mg-% (Fig. 5C) DEHP did not
appear significantly to affect the 51Cr plate-
let survival, i.e., recovery in vivo after trans-
fusion or mean lifespan of platelets. In three
studies in the same individual over a 1-yr
period, the bleeding time was corrected
within 24 hr of the infusion of platelet con-
centrates stored at 220 C for 24 hr. The
bleeding time was reduced within 2 hr of
infusion only after the transfusion of plate-
let concentrates stored in 35 mg-% DEHP
(Fig. 5A). Platelet concentrates stored in
bioriented polyolefin containing less than 1
mg-% DEHP had 51Cr recovery in vivo and
lifespan values similar to those of platelet
concentrates stored at 220C for 24 hr with
35 mg-% DEHP (Fig. 5B).
Figure 6 shows the effect of storage of
platelet concentrates at 40 C for 24 hr in
either poly(vinyl chloride) plastic (PL-146)
(Fig. 6A, C) or bioriented polyolefin con-
tainers (Fig. 6B) on the platelet survival and
the ability of the platelet concentrates to
correct the prolonged bleeding time induced
by aspirin treatment of a healthy volunteer.
Three separate studies over a 1-yr period
were performed on R.P. (Fig. 6). Platelet
concentrates stored at 40C for 24 hr with 7
mg-% and with 18 mg-% DEHP had similar
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FIGURE 5. Effect of autologous platelet concentrates obtained from a healthy volunteer (J.F.) prepared
from CPD whole blood and stored at 220C for 24 hr in either poly(vinyl chloride) plastic (PL-146) (A, C)
or in bioriented polyolefin plastic (B) on the bleeding time prolonged by the treatment with 650 mg of
aspirin. In the third study (C), a platelet concentrate was stored at 22 C for 48 hr in PL-146 and the
supernatant of the platelet concentrate was added to a fresh platelet concentrate and then stored for 24
hr at 220C. The 5ICr survival in vivo of the autologous platelet concentrates and the in vitro recovery of
the platelets from CPD whole blood and the index of therapeutic effectiveness (ITE) are also reported.
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platelets from CPD whole blood and the index of therapeutic effectiveness (ITE) are also shown.
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11551Cr survival values in uivo. There was a
slight improvement in--5IOr of plate-
lets stored in bioriented polyolefn con-
tainers with less than 1 mg-% JI{HP (Fig.
6B). The platelet concentrates stored in bi-
oriented polyolefin and poly(vinyl chloride)
plastic containers with 15 mg-% DEHP cor-
rected the bleeding time within 2 hr after
infusion. The transfusion of a unit of plate-
let concentrate after storage at 40C for 24
hr in a poly(vinyl chloride) plastic container
with 7 mg-% DEHP corrected the bleeding
time within 24 hr (Fig. 6A).
Discussion
Significant quantities of DEHP were pres-
ent in the plasma of whole blood collected
in ACD and in CPD anticoagulants and
stored at 4°C. Whole blood collected and
stored in the ACD anticoagulant had signifi-
cantly more DEHP on the day of collection
and after storage at 4°C than did the CPD
whole blood (Fig. 1). The reason for this
difference is not known. Our findings on
DEHP accumulation in ACD whole blood
were similar to those of Jaeger and Rubin
(12). We found very little DEHP in the
washed red cells, a finding similar to that of
Jaeger and Rubin (12).
We found that when whole blood is
stored in ACD for about 33 days and
washed by continuous-flow centrifugation
washing systems, about 98% of the DEHP is
removed (Table 1). When red cells were
frozen with either 40% (w/v) glycerol or
20% (w/v) glycerol in poly(vinyl chloride)
plastic bags or in bioriented polyolefin plas-
tic containers, the amount of DEHP in the
supernatant of the thawed glycerolized red
cells was the same as that present in the
ACD and CPD blood at the time of freezing
(Table 2). About 1 mg DEHP remained in
the washed previously frozen red cells after
storage at -80°C in 40% (w/v) glycerol or at
-150°C in 20% (w/v) glycerol (Tables 3 and
4).
No DEHP was found in bioriented poly-
olefin or polyethylene plastic containers, in
the 0.9% sodium chloride solution, the re-
juvenation solutions, or in any of the four
anticoagulants stored in poly(vinyl chloride)
Vplastic bags (Tables 5 and 6).
D-r_ Table 7 show that DEHP accumu-
I-ted n the platelet-rich plasma
and inite uperiiat of the platelet con-
centrate an the DIKP accumulation
was increased after d -t-tthe blood
components at 220 C. The uper-taiiLofJ,he
platelet concentrates accumulated tIgt-
est amount of DEHP. Platelet-poor plma,m
washed red cells, and washed platelets con-
tained little DEHP; the reason for this is not
known. Jaeger and Rubin have suggested
that the DEHP is extracted from the poly-
(vinyl chloride) plastic container by lipo-
protein substances (12). Our data suggest
that the platelets themselves are involved in
the extraction of DEHP from the poly(vinyl
chloride) containers. Our data also suggest
that the platelets do not phagocytize the
DEHP, since this material accumulated
primarily in the supernatant of the platelet
concentrates and the washed platelets con-
tained only a small amount (Table 7).
Various investigators have studied the
effect of plastic containers on platelet sur-
vival and function (8-11). The accumulation
of DEHP in the supernatant of platelet con-
centrates stored at 4°C and at 22°C for up
to 72 hr prompted us to study the effects in
vitro of the addition of DEHP to platelet-
rich plasma. Our data show that DEHP had
no significant effects in vitro on the re-
sponse of fresh platelet-rich plasma to ADP,
epinephrine, or collagen (Figs. 3 and 4).
Our data also show that DEHP had no
effect on 51Cr platelet survival or on the
hemostatic effectiveness of platelets in cor-
recting the prolonged bleeding time induced
by aspirin administration to healthy volun-
teers. When platelet concentrates were stored
at 220C for up to 72 hr there was no rela-
tion between the lifespan of the platelets
and the preservation injury (Fig. 2). The
addition of DEHP to the platelet concen-
trates did not adversely affect the recovery
in vivo of 51Cr-labeled platelets (Figs. 5 and
6). These data suggest that the reduced
Environmental Health Perspectives 116recovery in vivo noted during the 2-hr
period after the transfusion of platelet con-
centrates stored at 22°C for up to 72 hr
(Fig. 2) was not related to the DEHP con-
centration (Fig. 5). In our studies, the pres-
ence of DEHP had no apparent effect on
platelet function or survival in vivo (Figs. 5
and 6).
The accumulation of significant amounts
of DEHP observed in whole blood after stor-
age in poly(vinyl chloride) plastic containers
may be related to the microaggregates that
form in the blood during storage at 40C
(30-32). The microaggregates may be a
factor in the pulmonary insufficiency that
occurs after massive transfusion of stored
blood, and they may also affect the micro-
circulation of other organs (30).
Our data show that the accumulation of
DEHP during storage of blood products in
poly(vinyl chloride) plastic bags does not
adversely affect platelet function or survival.
However, the potential toxic effects of
DEHP in vivo and its metabolism in man
have not yet been defined.
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